Aberrant KIF20A Expression Is Associated with Adverse Clinical Outcome and Promotes Tumor Progression in Prostate Cancer

Figure 1

KIF20A expression in prostate cancer and biochemical recurrence- (BCR-) free survival for PCa patients according to the KIF20A expression. (a) The expression of KIF20A at the mRNA level in 7 PCa patients by qPCR. (b) The expression of KIF20A at the protein level in 7 PCa patients by Western blotting. (c) Immunoreactive KIF20A expression in 114 PCa patients (tumor vs. paracancerous tissues; paraffin section). (d) BCR-free survival in PCa patients according to the KIF20A expression from the TCGA dataset. Blue line indicates low KIF20A expression (). Red line indicates high KIF20A expression (). Patients with high KIF20A expression showed significantly poorer BCR-free survival. Data represent . , , and .

(a)

(b)

(c)

(d)